COVID boosters targeting Omicron variants were just approved in the U.S.—they could be available in mere days

The supplements to Pfizer’s and Moderna’s initial jab are known as “bivalent” boosters, as they’ll target both BA.4 and BA.5, two Omicron subvariants currently dominating the U.S. and much of the world. Read More